Trial
NCT02548390
Study of Intravenous RXDX-107 in Patients With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Solid Tumor
Intervention
RXDX-107
Why stopped
Company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-25